Offered paper: Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against recently emerged variants

Ann-Kathrin Reuschl (University College London, UK)

14:45 - 15:00 Monday 26 April Afternoon

+ Add to Calendar

More sessions on Registration